• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    HCSG Reports Q3 2024 Results

    10/23/24 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care
    Get the next $HCSG alert in real time by email

    Delivers QoQ and YoY Growth In Revenue, Earnings and Cash Flow

    • Revenue of $428.1 million, in line with expectations.
    • Net income and diluted EPS of $14.0 million and $0.19.
    • Reported and adjusted cash flow from operations of $4.3 million and $19.0 million.
    • Reaffirms Q4 revenue estimate of $430.0 to $440.0 million and FY 2024 cash flow forecast of $40.0 to $55.0 million.

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended September 30, 2024.

    Ted Wahl, Chief Executive Officer, stated, "We're very pleased with our third quarter results, which underscore the positive momentum we're carrying into the fourth quarter. Executing on our three strategic priorities – driving growth, managing costs, and optimizing collections – is clearly paying off, resulting in sequential and year-over-year growth in revenue, earnings, and cash flow. Looking ahead, we are confident that our focus on these priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, enhance profitability, and maximize cash flow through 2025 and beyond."

    Third Quarter Results

    • Revenue was reported at $428.1 million, in line with the Company's expectations of $425.0 million to $435.0 million.
      • Housekeeping & laundry and dining & nutrition segment revenues and margins were $191.1 million and 6.4% and $237.0 million and 5.3%, respectively.
      • The Company's Q4 expected revenue range is $430.0 to $440.0 million.
    • Cost of services was reported at $364.7 million or 85.2%.
      • The Company's goal is to continue to manage cost of services, excluding CECL, in the 86% range.
    • SG&A was reported at $46.9 million; after adjusting for the $2.4 million increase in deferred compensation; actual SG&A was $44.5 million or 10.4%.
      • The Company's goal continues to be achieving SG&A in the 8.5% to 9.5% range.
    • Net income and diluted EPS were reported at $14.0 million and $0.19, respectively.
    • Adjusted EBITDA was reported at $24.8 million.
    • Cash flow and adjusted cash flow from operations was $4.3 million and $19.0 million, respectively.
      • The Company reaffirmed its 2024 adjusted cash flow from operations forecast in the range of $40.0 million to $55.0 million.

    Balance Sheet and Liquidity

    The Company's primary sources of liquidity are cash and cash equivalents, its revolving credit facility, and cash flow from operating activities. As of the end of the third quarter, the Company had a current ratio of 2.9 to 1, cash and marketable securities of $130.0 million, and a $500.0 million credit facility (inclusive of its $200.0 million accordion), which expires in November 2027.

    In 2024, the Company has repurchased over 350,000 shares, or $4.0 million, of its common stock through September 2024, including over 90,000 shares, or $1.0 million of its common stock during the third quarter. Since the February 2023 share repurchase authorization, the Company has repurchased 1.4 million shares, or $15.2 million of its common stock. The Company has 6.1 million shares remaining under its authorization.

    Upcoming Events and Conference Call

    The Company will be participating in the UBS Global Healthcare Conference on November 13, 2024 at the Terranea Resort Hotel in Rancho Palos Verdes, CA. The Company will also be participating in the Raymond James Sonoma Small Cap Summit on November 18, 2024 at The Lodge at Sonoma in Sonoma, CA.

    The Company will host a conference call on Wednesday, October 23, 2024, at 8:30 a.m. Eastern Time to discuss its results for the three months ended September 30, 2024. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the "Events & Presentations" section of the Investor Relations page on the Company's website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

    About Healthcare Services Group, Inc.

    Healthcare Services Group (NASDAQ:HCSG) is an experienced leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With more than 45 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients.

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

    This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "estimates," "will," "goal," and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; the impact of and future effects of the COVID-19 pandemic or other potential pandemics; having a significant portion of our consolidated revenues contributed by one customer during the nine months ended September 30, 2024; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers' compensation and general liability insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2023 under "Government Regulation of Customers," "Service Agreements and Collections," and "Competition" and under Item 1A. "Risk Factors" in such Form 10-K.

    These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results would be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

    In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

    USE OF NON-GAAP FINANCIAL INFORMATION

    To supplement HCSG's consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

    The Company is presenting adjusted cash flows used in operations, earnings before interest, taxes, depreciation and amortization ("EBITDA"), and EBITDA excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

    HEALTHCARE SERVICES GROUP, INC.

    CONSOLIDATED STATEMENTS OF INCOME (LOSS)

    (Unaudited)

    (in thousands, except per share data)

     

     

     

    For the Three Months Ended

     

    For the Nine Months Ended

     

     

    September 30,

     

    September 30,

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Revenue

     

    $

    428,149

     

    $

    411,388

     

     

    $

    1,277,870

     

    $

    1,247,549

    Operating costs and expenses:

     

     

     

     

     

     

     

     

    Cost of services

     

     

    364,730

     

     

     

    376,936

     

     

     

    1,108,383

     

     

     

    1,107,519

     

    Selling, general and administrative

     

     

    46,888

     

     

     

    39,047

     

     

     

    138,236

     

     

     

    120,523

     

    Income (loss) from operations

     

     

    16,531

     

     

     

    (4,595

    )

     

     

    31,251

     

     

     

    19,507

     

    Other income, net

     

     

    2,277

     

     

     

    (1,738

    )

     

     

    6,885

     

     

     

    1,249

     

    Income (loss) before income taxes

     

     

    18,808

     

     

     

    (6,333

    )

     

     

    38,136

     

     

     

    20,756

     

     

     

     

     

     

     

     

     

     

    Income tax provision (benefit)

     

     

    4,778

     

     

     

    (1,286

    )

     

     

    10,585

     

     

     

    5,878

     

    Net income (loss)

     

    $

    14,030

     

     

    $

    (5,047

    )

     

    $

    27,551

     

     

    $

    14,878

     

     

     

     

     

     

     

     

     

     

    Basic earnings (loss) per common share

     

    $

    0.19

     

     

    $

    (0.07

    )

     

    $

    0.37

     

     

    $

    0.20

     

     

     

     

     

     

     

     

     

     

    Diluted earnings (loss) per common share

     

    $

    0.19

     

     

    $

    (0.07

    )

     

    $

    0.37

     

     

    $

    0.20

     

     

     

     

     

     

     

     

     

     

    Basic weighted average number of common shares outstanding

     

     

    73,687

     

     

     

    74,364

     

     

     

    73,822

     

     

     

    74,446

     

     

     

     

     

     

     

     

     

     

    Diluted weighted average number of common shares outstanding

     

     

    73,926

     

     

     

    74,364

     

     

     

    74,007

     

     

     

    74,496

     

    HEALTHCARE SERVICES GROUP, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (in thousands)

     

     

    September 30, 2024

     

    December 31, 2023

    Cash and cash equivalents

    $

    27,055

     

    $

    54,330

    Restricted cash equivalents

     

    1,084

     

     

     

    —

     

    Marketable securities, at fair value

     

    76,776

     

     

     

    93,131

     

    Restricted marketable securities, at fair value

     

    25,085

     

     

     

    —

     

    Accounts and notes receivable, net

     

    406,495

     

     

     

    383,509

     

    Other current assets

     

    41,623

     

     

     

    40,726

     

    Total current assets

     

    578,118

     

     

     

    571,696

     

     

     

     

     

    Property and equipment, net

     

    28,435

     

     

     

    28,774

     

    Notes receivable — long-term, net

     

    22,908

     

     

     

    24,832

     

    Goodwill

     

    75,529

     

     

     

    75,529

     

    Other intangible assets, net

     

    10,113

     

     

     

    12,127

     

    Deferred compensation funding

     

    48,647

     

     

     

    40,812

     

    Other assets

     

    42,091

     

     

     

    36,882

     

    Total assets

    $

    805,841

     

     

    $

    790,652

     

     

     

     

     

    Accrued insurance claims — current

    $

    21,510

     

     

    $

    22,681

     

    Other current liabilities

     

    175,694

     

     

     

    194,247

     

    Total current liabilities

     

    197,204

     

     

     

    216,928

     

     

     

     

     

    Accrued insurance claims — long-term

     

    61,520

     

     

     

    61,697

     

    Deferred compensation liability — long-term

     

    48,915

     

     

     

    41,186

     

    Lease liability — long-term

     

    9,029

     

     

     

    11,235

     

    Other long-term liabilities

     

    425

     

     

     

    2,990

     

    Stockholders' equity

     

    488,748

     

     

     

    456,616

     

    Total liabilities and stockholders' equity

    $

    805,841

     

     

    $

    790,652

     

    HEALTHCARE SERVICES GROUP, INC.

    RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

    (Unaudited)

     

    Reconciliation of GAAP net income (loss) to EBITDA and adjusted EBITDA (in thousands)

     

    For the Three Months Ended

    September 30,

     

    For the Nine Months Ended

    September 30,

     

     

     

     

    2024

     

     

     

    2023(1)

     

     

     

    2024

     

     

     

    2023(1)

     

    GAAP net income (loss)

     

    $

    14,030

     

     

    $

    (5,047

    )

     

    $

    27,551

     

     

    $

    14,878

     

    Income tax provision (benefit)

     

     

    4,778

     

     

     

    (1,286

    )

     

     

    10,585

     

     

     

    5,878

     

    Interest, net

     

     

    (6

    )

     

     

    530

     

     

     

    132

     

     

     

    1,119

     

    Depreciation and amortization(2)

     

     

    3,773

     

     

     

    3,250

     

     

     

    10,983

     

     

     

    10,565

     

    EBITDA

     

    $

    22,575

     

     

    $

    (2,553

    )

     

    $

    49,251

     

     

    $

    32,440

     

    Share-based compensation

     

     

    2,231

     

     

     

    2,384

     

     

     

    6,828

     

     

     

    6,793

     

    (Gain)/loss on deferred compensation, net(3)

     

     

    (1

    )

     

     

    (15

    )

     

     

    (40

    )

     

     

    67

     

    Adjusted EBITDA

     

    $

    24,805

     

     

    $

    (184

    )

     

    $

    56,039

     

     

    $

    39,300

     

    Adjusted EBITDA as a percentage of revenue

     

     

    5.8

    %

     

     

    0.0

    %

     

     

    4.4

    %

     

     

    3.2

    %

    Reconciliation of GAAP cash flows provided by (used in) operations to adjusted cash flows provided by operations (in thousands)

     

    For the Three Months Ended

     

    For the Nine Months Ended

     

    September 30,

     

    September 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    GAAP cash flows provided by (used in) operations

     

    $

    4,312

     

    $

    2,940

     

    $

    (5,402

    )

     

    $

    (5,947

    )

    Accrued payroll(4)

     

     

    14,682

     

     

     

    15,657

     

     

     

    12,820

     

     

     

    16,118

     

    Adjusted cash flows provided by operations

     

    $

    18,994

     

     

    $

    18,597

     

     

    $

    7,418

     

     

    $

    10,171

     

    1.

    For the three and nine months ended September 30, 2023, the Company's presentation of GAAP Net Income (Loss) has been revised to reflect the impact of an accounting error related to the Company's estimate for accrued vacation that was immaterial to the Company's previously reported consolidated financial statements or unaudited interim condensed consolidated financial statements. The Company's presentation of EBITDA and Adjusted EBITDA have also been revised to reflect the removal of certain reconciling items between reported GAAP figures and non-GAAP figures.

    2.

    Includes right-of-use asset depreciation of $2.0 million and $5.8 million for the three and nine months ended September 30, 2024, respectively, and $1.8 million and $4.6 million for the three and nine months ended September 30, 2023.

    3.

    The Company offers a Supplemental Executive Retirement Plan ("SERP") for executives and certain key employees which is also referred to as the Company's "Deferred Compensation" plan. For SERP participants, the Company has historically retained, and anticipates continuing to retain, 100% of the funds received from SERP participants and holds such assets (the "Deferred Compensation Assets") in a brokerage account where the investments are managed to mirror the investment elections of SERP participant holdings under such plans (the "Deferred Compensation Liabilities"). The Company's changes in fair market value of the Deferred Compensation Assets are presented under the "Other income, net" caption on the Company's Consolidated Statements of Comprehensive Income, however the corresponding and offsetting changes in the fair market value of the Deferred Compensation Liabilities are presented under the "Selling, general and administrative expense" caption.

    4.

    The accrued payroll adjustment reflects changes in accrued payroll for the three and nine months ended September 30, 2024 and 2023. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company's quarterly cash flow performance.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241023384049/en/

    Get the next $HCSG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCSG

    DatePrice TargetRatingAnalyst
    7/29/2025$16.00Neutral → Outperform
    Macquarie
    4/24/2025$15.00Neutral → Buy
    UBS
    12/16/2024Neutral
    Macquarie
    3/24/2023$8.50 → $14.00Underperform → Hold
    Jefferies
    2/17/2023$14.00 → $17.00Sector Perform → Outperform
    RBC Capital Mkts
    10/20/2022$18.00Hold → Buy
    The Benchmark Company
    2/10/2022$19.00 → $13.50Hold → Underperform
    Jefferies
    10/22/2021$28.00 → $22.00Neutral
    Credit Suisse
    More analyst ratings

    $HCSG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Provides Update On Client Restructuring, Reiterates 2025 Growth and Cash Flow Expectations

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today issued the following statement related to the Genesis HealthCare, Inc. ("Genesis") announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Texas on July 9, 2025 (the "Petition Date"). HCSG currently provides services to 164 Genesis facilities. Following the Petition Date, HCSG expects to continue its contractual relationship with those Genesis facilities without disruption in service or payments. As of the Petition Date, the estimated accounts and notes receivable balances of Genesis, net of reserves, were $50.0 million and $14.4 million, respectively. As a result of the Genesis filing, HCSG estima

    7/10/25 1:07:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports First Quarter Results

    Delivers Strong Revenue, Earnings & Cash Flow Revenue of $447.7 million, an increase of 5.7% over the prior year. Net income and diluted EPS of $17.2 million and $0.23. Reported cash flow from operations of $27.5 million; cash flow from operations (excluding the change in payroll accrual) of $32.1 million, an increase of $41.3 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $45.0 to $60.0 million to $60.0 to $75.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended March 31, 2025. Ted Wahl, Chief Ex

    4/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simmons Kurt Jr was granted 892 shares, increasing direct ownership by 3% to 26,596 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    10/2/25 4:09:36 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Director Whalen Thomas Gerard was granted 149 shares, increasing direct ownership by 5% to 3,020 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    10/2/25 4:07:50 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    EVP & Chief Admin. Officer Shea John Christopher sold $283,126 worth of shares (21,368 units at $13.25), decreasing direct ownership by 39% to 32,976 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    7/30/25 4:20:05 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    SEC Filings

    View All

    SEC Form 10-Q filed by Healthcare Services Group Inc.

    10-Q - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/25/25 4:03:10 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/23/25 7:10:38 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/10/25 2:49:55 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Healthcare Services Group upgraded by Macquarie with a new price target

    Macquarie upgraded Healthcare Services Group from Neutral to Outperform and set a new price target of $16.00

    7/29/25 10:30:39 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group upgraded by UBS with a new price target

    UBS upgraded Healthcare Services Group from Neutral to Buy and set a new price target of $15.00

    4/24/25 7:18:16 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Macquarie initiated coverage on Healthcare Services Group

    Macquarie initiated coverage of Healthcare Services Group with a rating of Neutral

    12/16/24 7:46:05 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Financials

    Live finance-specific insights

    View All

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Provides Update On Client Restructuring, Reiterates 2025 Growth and Cash Flow Expectations

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today issued the following statement related to the Genesis HealthCare, Inc. ("Genesis") announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Texas on July 9, 2025 (the "Petition Date"). HCSG currently provides services to 164 Genesis facilities. Following the Petition Date, HCSG expects to continue its contractual relationship with those Genesis facilities without disruption in service or payments. As of the Petition Date, the estimated accounts and notes receivable balances of Genesis, net of reserves, were $50.0 million and $14.4 million, respectively. As a result of the Genesis filing, HCSG estima

    7/10/25 1:07:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports First Quarter Results

    Delivers Strong Revenue, Earnings & Cash Flow Revenue of $447.7 million, an increase of 5.7% over the prior year. Net income and diluted EPS of $17.2 million and $0.23. Reported cash flow from operations of $27.5 million; cash flow from operations (excluding the change in payroll accrual) of $32.1 million, an increase of $41.3 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $45.0 to $60.0 million to $60.0 to $75.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended March 31, 2025. Ted Wahl, Chief Ex

    4/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    11/13/24 5:15:34 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    10/15/24 1:08:04 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Healthcare Services Group Inc. (Amendment)

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    2/13/24 5:06:23 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Leadership Updates

    Live Leadership Updates

    View All

    HCSG Announces Appointment of Chief Financial Officer

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today announced the appointment of Vikas Singh as EVP & Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy. Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began

    9/9/24 12:00:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care